Compounding: How Does FDA Expand Oversight Without Legislation?

FDA may have to downshift to guidance or potentially judicial options to expand its oversight of compounding now that any legislation to expand its authority appears to be unlikely.

House Republicans indicated during a combative hearing with FDA Commissioner Margaret Hamburg that agency policy changes may suffice and suggested FDA work to maximize the authority it already has to...